Elevated Plasma Homocysteine Was Associated With Hemorrhagic and Ischemic Stroke, but Methylenetetrahydrofolate Reductase Gene C677T Polymorphism Was a Risk Factor for Thrombotic Stroke
- 1 September 2003
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 34 (9), 2085-2090
- https://doi.org/10.1161/01.str.0000086753.00555.0d
Abstract
Background and Purpose— It is still controversial whether elevated plasma homocysteine and the C677T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene are risk factors for stroke. The aim of the present study was to investigate the association between the 2 factors and stroke in Chinese in a large case-control study. Methods— We recruited 1823 stroke patients (807 cerebral thrombosis, 513 lacunar infarction, 503 intracerebral hemorrhage) and 1832 controls. Total plasma homocysteine was determined by high-performance liquid chromatography. C677T polymorphism was genotyped by polymerase chain reaction and Hin fI digestion. Results— Total plasma homocysteine levels were significantly higher in cases than controls (median, 14.7 versus 12.8 μmol/L; P P P P =0.017). The TT genotype was associated with an increased risk for overall stroke (odds ratio, 1.27; 95% CI, 1.04 to 1.56) and thrombotic stroke (odds ratio, 1.37; 95% CI, 1.06 to 1.78). Conclusions— The C677T polymorphism of the MTHFR gene was associated with increased risk of cerebral thrombotic stroke in Chinese. Total plasma homocysteine was correlated with both ischemic and hemorrhagic stroke, suggesting potential initiation of homocysteine-lowering therapy in this population.This publication has 19 references indexed in Scilit:
- Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine modelJCI Insight, 2001
- C677T MTHFR Mutation and Factor V Leiden Mutation in Patients with TIA/Minor Stroke: A Case-Control StudyThrombosis Research, 1999
- Homocysteine and Short-term Risk of Myocardial Infarction and Stroke in the ElderlyArchives of Internal Medicine, 1999
- Plasma Homocysteine as a Risk Factor for Vascular DiseasePublished by American Medical Association (AMA) ,1997
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery StenosisNew England Journal of Medicine, 1995
- World Health Statistics Quarterly 1993.Biometrics, 1994
- Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis, 1994
- Predicting Glomerular Function from Adjusted Serum CreatinineNephron, 1992
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988